[Fwd: Fw: [Ip-health] It is time to nationalize the international
pharmaceutical industry]
Michael H. Davis
michael.davis@law.csuohio.edu
Sat, 06 Oct 2001 11:51:11 +0000
This is a multi-part message in MIME format.
--------------21C9D284A9DCA0A964A74EEB
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
--
You can access my papers on the Social Science Research Network (SSRN)
through the following url:
http://papers.ssrn.com/sol3/cf_dev/AbsByAuth.cfm?per_id=230701
--------------21C9D284A9DCA0A964A74EEB
Content-Type: message/rfc822
Content-Transfer-Encoding: 7bit
Content-Disposition: inline
Delivered-To: michael.davis@law.csuohio.edu
Return-Path: <dean.baker@worldnet.att.net>
Received: from mtiwmhc22.worldnet.att.net (mtiwmhc22.worldnet.att.net [204.127.131.47])
by law.csuohio.edu with esmtp; Fri, 05 Oct 2001 22:03:57 -0400
Received: from 152174824worldnet ([12.78.178.248])
by mtiwmhc22.worldnet.att.net
(InterMail vM.4.01.03.16 201-229-121-116-20010115) with SMTP
id <20011006020917.RMJP8481.mtiwmhc22.worldnet.att.net@152174824worldnet>
for <michael.davis@law.csuohio.edu>;
Sat, 6 Oct 2001 02:09:17 +0000
Message-ID: <003201c14e0a$af6ed3c0$f8b24e0c@152174824worldnet.att.net>
From: "Dean Baker" <dean.baker@worldnet.att.net>
To: michael.davis@law.csuohio.edu
Subject: Fw: [Ip-health] It is time to nationalize the international pharmaceutical industry
Date: Fri, 5 Oct 2001 22:00:29 -0400
MIME-Version: 1.0
Content-Type: text/plain;
charset="iso-8859-1"
Content-Transfer-Encoding: 7bit
X-Priority: 3
X-MSMail-Priority: Normal
X-Mailer: Microsoft Outlook Express 4.72.3110.1
X-MimeOLE: Produced By Microsoft MimeOLE V4.72.3110.3
You're welcome to post this note to the list if you want. My posts are
mediated and sometimes take a while.
As you can imagine, I appreciated your comment.
Dean
-----Original Message-----
From: Dean Baker <dean.baker@worldnet.att.net>
To: Huff, Bob <bobhuff@GMHC.org>
Date: Friday, October 05, 2001 9:54 PM
Subject: Re: [Ip-health] It is time to nationalize the international
pharmaceutical industry
>If Mickey's position is lunacy, then there must be some research that shows
>that privately funded research is about four to five times as efficient
(the
>ratio of the additional costs due to patent protection to the amount of
>patent supported drug research) as publicly funded research. If anyone has
>seen this research, please pass along the references.
>
>Dean Baker
>
>
>-----Original Message-----
>From: Huff, Bob <bobhuff@GMHC.org>
>To: Prof. Michael H. Davis <michael.davis@law.csuohio.edu>
>Cc: IP-Health list <ip-health@venice.essential.org>
>Date: Friday, October 05, 2001 2:01 PM
>Subject: RE: [Ip-health] It is time to nationalize the international
>pharmaceutical industry
>
>
>>"It is time to nationalize the international pharmaceutical industry"
>>
>>Why stop there? Since nearly all intellectual property generated by US
>>citizens is directly dependent on publicly funded education, wouldn't we
be
>>better served if the media and entertainment industries were nationalized?
>>Certainly this would address the problem of over-priced movie tickets,
news
>>glut, and insipid action films. And since agriculture is so heavily
>>subsidized by government already, why not nationalize the farms? Shut down
>>the me-too producers of wheat and corn and grow more organic quinoa. And
>>what about foreign countries that are major recipients of US assistance?
>>Wouldn't we be in a better position to fight terrorism if we had simply
>>nationalized Israel and Afghanistan?
>>
>>Sorry for the sarcasm, but the lunacy of this exchange calls into question
>>what I had assumed were well-considered positions concerning other aspects
>>of your expertise. The buffoonery of Bale and Krebs aside... You're
>kidding,
>>right?
>>
>>Bob
>>
>>-----Original Message-----
>>From: Prof. Michael H. Davis [SMTP:michael.davis@law.csuohio.edu]
>>Sent: Friday, October 05, 2001 10:45 AM
>>To: James Love
>>Cc: IP-Health list
>>Subject: [Ip-health] It is time to nationalize the international
>>pharmaceutical industry
>>
>>> Since federal funding in the U.S., for instance, constitutes the bulk
>>> of investment in pharmaceuticals already, and the only important
>>> investment in important drugs (the industry relying on small-investment
>>> "me-too" drugs and baldness cures, for instance), it is only logical,
>>> in the face of industry threats to extort beneficial laws in exchange
>>> for production of essesntial drugs, to complete the process.
>>
>>There is no logic in having national airlines, national health care,
>>national universities, and national armies, and not having completely
>>national pharmaceutical production as well. Since most R&D is already
>>governmental, production and distribution should be nationalized as well.
>>Not only would this assure reasonable access to all medicines, research
>>directed at the most important problems, and transparency in cost-benefit
>>calculations, but it would avoid this kind of shameful blackmail that
>>arises every time citizens demand better pharmaceutical practices.
>>Instead of giving us what we deserve, the industry habitually threatens
>>to stop research unless it is given absolute property rights in knowledge
>>we all pay for by way of massive federal support for scientific research.
>>
>>And are the half-measures that have become the focus of this dispute
>>worthy of this battle?
>>
>>Mickey
>>
>>>
>>>
>>> Drug Companies Fight Back
>>>
>>> The International Federation of Pharmaceutical Manufacturers
>>> Associations issued a press release ... Several IFPMA officials added
>>> that efforts to
>>> broaden TRIPS would prompt drug firms to decrease their research and
>>> development for AIDS drugs. ... Bale and Krebs said that
>>> if patent regulations are eased for HIV/AIDS drugs, investors in drug
>>> firms would pressure the firms to "focus on other diseases that
>>> caused less controversy, like cancer" (Evans, Reuters, 9/19). The
>>> release states, "IFPMA calls on all [WTO] member states to take an
>>> active role in supporting strong implementation and enforcement of
>>> the TRIPS agreement ... Measures which focus on
>>> weakening intellectual property rights in the name of 'improving
>>> access,' however, will actually divert decision-makers away from
>>> addressing the real barriers to access" (IFPMA rele
>>> --
>>>
>>> Julie Davids
>>> ACT UP Philadelphia
>>> Health GAP Coalition
>>>
>>> c/o Critical Path AIDS Project
>>> 1233 Locust Street
>>> Philadelphia, PA 19107
>>> 215-474-9329
>>> _______________________________________________
>>> Ip-health mailing list
>>> Ip-health@lists.essential.org
>>> http://lists.essential.org/mailman/listinfo/ip-health
>>
>>--
>>You can access my papers on the Social Science Research Network (SSRN)
>>through the following url:
>>http://papers.ssrn.com/sol3/cf_dev/AbsByAuth.cfm?per_id=230701
>> << File: Card for Prof. Michael H. Davis >>
>>_______________________________________________
>>Ip-health mailing list
>>Ip-health@lists.essential.org
>>http://lists.essential.org/mailman/listinfo/ip-health
>>
>
--------------21C9D284A9DCA0A964A74EEB
Content-Type: text/x-vcard; charset=us-ascii;
name="michael.davis.vcf"
Content-Transfer-Encoding: 7bit
Content-Description: Card for Michael H. Davis
Content-Disposition: attachment;
filename="michael.davis.vcf"
begin:vcard
n:H.;Davis,
tel;fax:216-687-6881
tel;work:216-687-2228
x-mozilla-html:FALSE
org:Cleveland State University;College of Law
adr:;;1801 Euclid Avenue;Cleveland;OH;44115;
version:2.1
email;internet:michael.davis@law.csuohio.edu
title:Professor of Law
note;quoted-printable:Patent Attorney Admitted to Practice Before the United States Patent and Trademark Office=0D=0A=0D=0A
fn:Davis, Prof. Michael H.
end:vcard
--------------21C9D284A9DCA0A964A74EEB--